Loading company
Alamar Biosciences, Inc.
ALMR · Nasdaq · ·
Next earnings: November 9, 2026
$32.55-0.1%Sep 29 close
- 1M
- +6.0%
ALMR · Nasdaq · ·
Next earnings: November 9, 2026
$32.55-0.1%Sep 29 close
Alamar Biosciences, Inc. is scheduled to report next on November 9, 2026. The date comes from Nasdaq’s earnings calendar, and companies sometimes move it.
From the company’s own 8-K filing.
Alamar Biosciences, Inc. has no earnings call transcript available.
“We delivered a strong second quarter with consumable revenue growing nearly 150% year-over-year,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land after the close or before the open, so the move is the session that follows.
Alamar is a commercial-stage proteomics company establishing a gold standard in protein detection and analysis. Leveraging our proprietary NULISA technology and the ARGO HT System, our platform is designed to detect protein biomarkers at extremely low concentrations in blood with ultra-high sensitivity, high specificity, flexible multiplexing, broad dynamic range and seamless automation. We refer to this combination of features as “Precision Proteomics,” and believe it fills a critical gap in the field of advanced proteomics, helping researchers unlock the full spectrum of protein biomarkers across disease states. Learn more at alamarbio.com .
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Alamar Biosciences, Inc.’s Item 2.02 8-K filed August 10, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.